Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May...
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue...
The sun is shining this morning on the nation's medicine chest. Why not grab of cup of coffee or tea and catch up as you prepare to dive back into work?
Boston Scientic To Cut Up To 3,400 Jobs (The Boston Globe)
Forest Labs Reports Lower Second-Quarter Profits (Yahoo/AP)
Medtronic Sued By Patients Over Heart Device Problems (Bloomberg News)
Bristol Awaits FDA Approval For Breast Cancer Drug (Scientific American/Reuters)
